SUNRISE-CRC: a randomized phase II study of high-dose intermittent sunitinib ...

These data support the main findings described in 'SUNRISE-CRC: a randomized phase II study of high-dose intermittent sunitinib versus trifluridine/tipiracil in metastatic...本数据集支持《SUNRISE-CRC：一项在转移性……中开展的大剂量间歇给药舒尼替尼（sunitinib）对比曲氟尿苷替匹嘧啶（trifluridine/tipiracil）的随机II期临床试验》中所描述的主要研究结果。